Persistence Market Research Company
Customize Now Get FREE Sample

Targeted Cancer Therapies Market Size, Share, and Growth Forecast, 2026 - 2033

Targeted Cancer Therapies Market by Therapy Type (Monoclonal Antibodies, Signal Transduction Inhibitors, Hormone Therapies, Small Molecule Inhibitors), Disease Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Gastrointestinal), End-User (Hospitals, Cancer and Radiation Therapy Centers, Clinics), and Regional Analysis for 2026-2033

ID: PMRREP13807| 221 Pages | 14 Dec 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Targeted Cancer Therapies Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Disease Indication
  5. Global Targeted Cancer Therapies Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2026 – 2033
    3. Global Targeted Cancer Therapies Market Outlook: Therapy  Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Therapy  Type, 2020 – 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
        1. Monoclonal Antibodies
        2. Signal Transduction Inhibitors
        3. Hormone Therapies
        4. Small Molecule Inhibitors
      4. Market Attractiveness Analysis: Therapy  Type
    4. Global Targeted Cancer Therapies Market Outlook: Disease Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Disease Indication, 2020 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Gastrointestinal (GI) Cancer
      4. Market Attractiveness Analysis: Disease Indication
    5. Global Targeted Cancer Therapies Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-user, 2020 – 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 – 2033
        1. Hospitals
        2. Cancer and Radiation Therapy Centers
        3. Clinics
      4. Market Attractiveness Analysis: End-user
  6. Global Targeted Cancer Therapies Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 – 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  8. Europe Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  9. East Asia Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  11. Latin America Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  12. Middle East & Africa Targeted Cancer Therapies Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2024
      1. By Country
      2. By Therapy  Type
      3. By Disease Indication
      4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy  Type, 2026 – 2033
      1. Monoclonal Antibodies
      2. Signal Transduction Inhibitors
      3. Hormone Therapies
      4. Small Molecule Inhibitors
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 – 2033
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Gastrointestinal (GI) Cancer
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026-2033
      1. Hospitals
      2. Cancer and Radiation Therapy Centers
      3. Clinics
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. F. Hoffmann La Roche AG
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Pfizer Inc.
      3. Bristol Myers Squibb Company
      4. Novartis AG
      5. Merck & Co., Inc. (MSD)
      6. Johnson & Johnson (Janssen)
      7. Sanofi S.A
      8. AbbVie Inc.
      9. AstraZeneca plc
      10. Eli Lilly and Company
      11. Takeda Pharmaceutical Company Limited
      12. Astellas Pharma Inc.
      13. Teva Pharmaceutical Industries Ltd.
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

List Of Table

N/A

We use cookies to improve user experience.
Google translate